. , . , . , ; Lotus Development , . , , .
. , , . (Cairo 1983) , . :
1. . - .
2. .
3. , .
4. .
5. . .
, 1983 , , . , , . , () , , , , , (Smith, 1988).
, , .
|
|
1990- . , , , (Masi & Friedland, 1988). , , . , , , (Milne, Blum & Roman, 1994). , , , , (Bayer & Gerstein, 1990).
, , , , , - . , . (Ackerman, 1992; Ree, Caretta & Teachout, 1995), - , .
, , , (Fishbein & Stasson, 1990; Quinones, 1995); , (Hicks & Klimoski,1987); (Tannenbaum, Cannon-Bowers, Salas & Mathieu, 1993); (commitment) (Noe & Schmitt, 1986); (Mitchell, Hopper, Daniels, George-Falvy & James, 1994); (Gist, Rosen & Schwoerer, 1988; Morrison & Brantner, 1992). . , , .
, , , . (Karl, O'Leary-Kelly & Martocchio, 1993), , (Clark, Dobbins & Ladd, 1993).
, , , , , , , . , . , , . ; .
|
|
, - , , , . , ( ) (Louis, 1980). . , . . , , .
, , , . . , , , .
. , . 5.9. , . , . , DuPont Merck Phaimaceutical (Klein & Taylor, 1994).
DuPont Merck, , . , , - (sponsor), . , , .
1-3 , , . , DuPont Merck , . , , ( ), .
, , , . , . , - , , .